Reginald Oyortey

From Bench to Bedside: Structural and Biological Barriers to Therapeutic Translation in Pancreatic Cancer

Reginald Oyortey, Tosin Abiodun Aderanti, Ngwoke, Chinaza Faith, Esosa Omoregie, Anointing Akindele, Salifu Faisal & Bethel Abioke Uchechukwu · Journal of Cancer and Tumor International · 2026

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, driven largely by KRAS mutations and profound therapeutic resistance. This review summarizes recent translational strategies aimed at bridging laboratory discoveries with clinical application, including...

Open access Research Article 10.9734/jcti/2026/v16i1345

Systematic Review of Multitarget Natural Products and Phytochemicals for Neurodegenerative Disease Therapy and Therapeutic Potentials

Verity Ghansah, Reginald Oyortey, Rachael Boluwatife Oke, Oyinlade Cecilia Ogundare, Onanuga Daniel Adeola, Aghahowa Iredoman Edward & Mariam Iyabo Adeoba · South Asian Research Journal of Natural Products · 2026

Background: Neurodegenerative diseases are severe and incurable health issues that affect millions of people. Phytochemicals are being increasingly studied, for their multitarget effects. Aim: The objective is to examine research studies on multitarget natural products and phytoc...

Open access Research Article 10.9734/sarjnp/2026/v9i2243

Next-Gen Gene Editing and Programmable Chromosome Engineering for Potential Cancer Gene Mutation Therapeutics

Salvation Ifechukwude Atalor, Jumoke Ologun, Modinat Aina, Abayomi, Obiageri Ihuarulam Okeoma, Opeoluwa Alayande, Awah Favour Matthew, Reginald Oyortey & Lawrence John AJutor · International Research Journal of Oncology · 2025

Gene editing technologies have revolutionized the approach to treating cancer by enabling precise modifications to the genome, particularly through programmable chromosome engineering techniques that allow for large-scale rearrangements, deletions, and insertions to correct or di...

Open access Research Article 10.9734/irjo/2025/v8i2187